RGC
Regencell Bioscience Holdings Ltd
6.20$
+0.0%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
Regencell Bioscience Holdings Ltd (RGC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 5.8 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,705 | 2,540 | 2,632 | 2,646 | 2,843 | 0.2 | 0.5 | 0.3 | 18 | 13 | 8.4 | 5.8 | |
| 465 | 341 | 438 | 447 | 463 | 0.2 | 0.4 | 0.1 | 16 | 12 | 8.1 | 4.9 | |
| 281 | 147 | 220 | 247 | 229 | 0.2 | 0.4 | 0.1 | 6.4 | 1.6 | 3.0 | 2.4 | |
| 288 | 151 | 220 | 247 | 229 | 0.2 | 0.4 | 0.1 | 16 | 12 | 8.0 | 4.9 | |
| 129 | – | 153 | 155 | 184 | – | – | 0.0 | 0.0 | 0.1 | 0.2 | – | |
| 19 | 18 | 22 | 21 | 23 | – | – | 0.0 | 0.0 | -0.1 | -0.2 | – | |
| – | – | – | – | – | – | 0.1 | 0.1 | 1.5 | – | – | – | |
| 320 | 320 | 329 | 327 | 346 | – | – | – | – | – | – | – | |
| 58 | 54 | 50 | 46 | 44 | – | – | – | – | – | – | – | |
| 3,418 | 3,434 | 3,510 | 3,485 | 3,699 | 2.1 | 3.2 | 4.3 | 0.9 | 0.6 | 0.2 | 0.9 | |
| 506 | 477 | 551 | 510 | 561 | 2.1 | 3.2 | 4.3 | 0.6 | 0.6 | 0.2 | 0.7 | |
| 30 | 27 | 27 | 26 | 27 | 2.1 | 3.1 | 3.7 | 0.4 | 0.4 | 0.1 | 0.3 | |
| 170 | 166 | 230 | 195 | 232 | – | – | – | – | – | – | – | |
| -713 | -895 | -878 | -839 | -856 | -1.8 | -2.7 | -4.0 | 17 | 12 | 8.2 | 4.9 | |
| 72 | 48 | 64 | 97 | 71 | -1.8 | -2.7 | -4.0 | -11 | -17 | -22 | -25 | |
| 5,917 | 5,940 | 5,947 | 5,958 | 5,965 | 480 | 480 | 480 | 494 | 494 | 494 | 494 |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.